ATEC — Alphatec Holdings, Inc.

Summary of Alphatec Holdings, Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 2025 Revenue: $213 million, a 20% increase year-over-year.
• Surgical Revenue: $190 million (21% growth), with same-store sales up 20%.
• EOS Revenue: $23 million, a 14% increase.
• Adjusted EBITDA: $33 million, up 61% year-over-year, with a margin of 16%.
• Full Year 2025 Revenue: $764 million, a 25% increase from the previous year.
• Full Year Adjusted EBITDA: $93 million (12% margin), up $63 million year-over-year.
• Free Cash Flow: $8 million in Q4 and $3 million for the full year.
• Cash Position: $161 million in cash and $60 million available on a revolving credit line.

2. Strategic Updates and Business Highlights:

• Alphatec is focusing exclusively on the spine market, emphasizing leadership in lateral and deformity surgery.
• Key product advancements include the EOS Insight system, a bone mineral density test, and a range of new 3D-printed implants.
• The company is expanding its sales force and enhancing its procedural ecosystem, which integrates technology and data into surgical practices.
• An exclusive distribution partnership with Theradaptive aims to introduce a new bone morphogenetic protein (BMP) product, expected to significantly impact the market.

3. Forward Guidance and Outlook:

• For 2026, Alphatec expects revenue growth of 17%, targeting approximately $890 million, with surgical revenue projected at $805 million.
• Adjusted EBITDA guidance for 2026 is set at $134 million (15% margin).
• The company anticipates continued surgeon adoption and utilization growth, with a focus on expanding its market share in spine surgery.

4. Bad News, Challenges, or Points of Concern:

• There were indications of changing seasonal patterns in revenue, which may affect future quarterly performance.
• The international business is contributing lower average revenue per case, which could impact overall margins.
• The company noted that year-over-year growth in Q4 was less pronounced compared to previous quarters, which may raise concerns about sustaining momentum.

5. Notable Q&A Insights:

• Analysts questioned the stock's post-earnings performance despite positive results, seeking clarity on market reactions.
• Management confirmed that they are attracting top sales talent and noted strong demand for their product portfolio.
• There was discussion about the potential for changing seasonal revenue patterns, with management providing insights on expected quarterly performance for 2026.

Overall, Alphatec Holdings, Inc. reported strong financial results for Q4 2025 and the full year, with a positive outlook for 2026 driven by strategic initiatives and product innovations, although there are some concerns regarding seasonal revenue patterns and international market performance.